Nonprescription statins: not ready for prime time.

Suppr

超能文献

作者信息

Whayne Thomas F

出版信息

Am J Cardiol. 2008 Mar 1;101(5):745-6; author reply 746. doi: 10.1016/j.amjcard.2007.09.112.

DOI:10.1016/j.amjcard.2007.09.112

PMID:18308034

Abstract

摘要

相似文献

Nonprescription statins: not ready for prime time.

Am J Cardiol. 2008 Mar 1;101(5):745-6; author reply 746. doi: 10.1016/j.amjcard.2007.09.112.

A new perspective on nonprescription statins: an opportunity for patient education and involvement.

Am J Cardiol. 2007 Sep 1;100(5):907-10. doi: 10.1016/j.amjcard.2007.06.009. Epub 2007 Jul 10.

Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.

Circulation. 2006 Sep 19;114(12):1315-20; discussion 1320. doi: 10.1161/CIRCULATIONAHA.105.604991.

Primary prevention with over-the-counter statins: a cautionary tale.

Clin Pharmacol Ther. 2005 Sep;78(3):218-20. doi: 10.1016/j.clpt.2005.06.001.

Is it appropriate to make statins available over the counter? Over-the-counter statins are worth considering in primary prevention of cardiovascular disease.

Circulation. 2006 Sep 19;114(12):1310-4; discussion 1314. doi: 10.1161/CIRCULATIONAHA.105.552257.

Statins for primary prevention of coronary artery disease.

Lancet. 2007 Mar 31;369(9567):1078-9; author reply 1079. doi: 10.1016/S0140-6736(07)60518-2.

Influenza vaccine does not produce myopathy in patients taking statins.

J Fam Pract. 2002 Nov;51(11):986, 988.

Intensive lipid-lowering therapy: obvious benefits, possible risks.

Isr Med Assoc J. 2006 Dec;8(12):890-1.

Statins and myopathy.

N Z Med J. 2005 Dec 16;118(1227):U1798.

Lipid-lowering therapy--benefits and risks.

Isr Med Assoc J. 2007 Feb;9(2):133; author reply 133-4.

引用本文的文献

A viewpoint on statin effects − benefits and problems.

Int J Angiol. 2008 Winter;17(4):178-80. doi: 10.1055/s-0031-1278305.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Nonprescription statins: not ready for prime time.

Am J Cardiol. 2008 Mar 1;101(5):745-6; author reply 746. doi: 10.1016/j.amjcard.2007.09.112.

A new perspective on nonprescription statins: an opportunity for patient education and involvement.

Am J Cardiol. 2007 Sep 1;100(5):907-10. doi: 10.1016/j.amjcard.2007.06.009. Epub 2007 Jul 10.

Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.

Circulation. 2006 Sep 19;114(12):1315-20; discussion 1320. doi: 10.1161/CIRCULATIONAHA.105.604991.

Primary prevention with over-the-counter statins: a cautionary tale.

Clin Pharmacol Ther. 2005 Sep;78(3):218-20. doi: 10.1016/j.clpt.2005.06.001.

Is it appropriate to make statins available over the counter? Over-the-counter statins are worth considering in primary prevention of cardiovascular disease.

Circulation. 2006 Sep 19;114(12):1310-4; discussion 1314. doi: 10.1161/CIRCULATIONAHA.105.552257.

Statins for primary prevention of coronary artery disease.

Lancet. 2007 Mar 31;369(9567):1078-9; author reply 1079. doi: 10.1016/S0140-6736(07)60518-2.

Influenza vaccine does not produce myopathy in patients taking statins.

J Fam Pract. 2002 Nov;51(11):986, 988.

Intensive lipid-lowering therapy: obvious benefits, possible risks.

Isr Med Assoc J. 2006 Dec;8(12):890-1.

Statins and myopathy.

N Z Med J. 2005 Dec 16;118(1227):U1798.

Lipid-lowering therapy--benefits and risks.

Isr Med Assoc J. 2007 Feb;9(2):133; author reply 133-4.

引用本文的文献

A viewpoint on statin effects − benefits and problems.

Int J Angiol. 2008 Winter;17(4):178-80. doi: 10.1055/s-0031-1278305.